(资料图片) 近5日资金流向一览见下表： 该股为动物保健，光伏概念热股，当日动物保健概念上涨0.95%，光伏概念上涨0.11%。 以上内容由证券之星根据公开信息整理，与本站立场无关。证券之星不保证该信息（包括但不限于文 字、视频、音频、数据及图表）全部或者部分内容的的准确性、完整性、有效性、及时性等，如存在问 题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。 绿康生化涨停收盘，收盘价20.33元。该股于9点25分涨停，未打开涨停，截止收盘封单资金为8128.01万 元，占其流通市值2.57%。 资金流向数据方面，8月5日主力资金净流入850.6万元，游资资金净流出524.89万元，散户资金净流出 325.71万元。 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300871 | 回盛生物 | 23.52 | -5.24% | 27.00万 | 6.43 乙 | | 688098 | 申联生物 | 8.51 | -3.62% | 29.97万 | 2.57亿 | | 002868 | *ST绿康 | 26.30 | -1.50% | 1.45万 | 3804.68万 | | 603718 | 海利生物 | 7.58 | -1.17% | 9.42万 | 7168.65万 | | 688526 | 科前生物 | 16.96 | -0.88% | 3.74万 | 6337.08万 | | 839729 | 永顺生物 | 10.02 | -0.79% | 4.50万 | 4535.21万 | | 600195 | 中牧股份 | 7.61 | -0.78% | 9.50万 | 7231.88万 | | 838275 | 驱动力 | 10.02 | -0.60% | 1.65万 | 1640.86万 | | 6035 ...

Group 1: New Stock Offerings - Shenke Co., Ltd. (002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17, 2025, to August 15, 2025[1] - ST Zitian (300280) has a tender offer period ending on July 21, 2025[1] Group 2: Market Alerts - Xizang Tourism (600749) reported severe abnormal fluctuations on July 31, 2025[1] - Tianlu Convertible Bonds (110060) announced significant market activity on July 30, 2025[1] - ST Suwu (600200) experienced unusual trading patterns on July 30, 2025[1] Group 3: Additional Announcements - Happiness Blue Ocean (300528) issued a notice on July 30, 2025, regarding market conditions[1] - Common Pharmaceutical (300966) provided updates on August 1, 2025, related to stock performance[1] - Dongjie Intelligent (300486) released a statement on August 1, 2025, concerning market volatility[1]

Market Overview - The animal health sector increased by 0.65% on August 4, with BioShares leading the gains [1] - The Shanghai Composite Index closed at 3583.31, up 0.66%, while the Shenzhen Component Index closed at 11041.56, up 0.46% [1] Stock Performance - BioShares (600201) closed at 8.75, rising by 2.70% with a trading volume of 327,100 shares and a turnover of 280 million yuan [1] - Jinhe Biology (002688) closed at 7.34, up 2.51%, with a trading volume of 666,900 shares and a turnover of 485 million yuan [1] - Ruipu Biology (300119) closed at 21.58, increasing by 1.27%, with a trading volume of 72,800 shares and a turnover of 155 million yuan [1] - KQ Biology (688526) closed at 17.00, up 1.01%, with a trading volume of 29,600 shares and a turnover of 49.88 million yuan [1] - Other notable stocks include Dayu Biology (871970) at 10.40 (+0.97%) and Zeng Caike (603566) at 15.00 (+0.87%) [1] Capital Flow - The animal health sector saw a net inflow of 68.12 million yuan from institutional investors, while retail investors experienced a net outflow of 58.45 million yuan [2] - The main capital inflow and outflow for specific stocks include: - Jinhe Biology: 70.12 million yuan inflow from main investors, 33.36 million yuan outflow from retail investors [3] - BioShares: 15.45 million yuan inflow from main investors, 8.61 million yuan outflow from retail investors [3] - Shilian Biology (688098): 3.79 million yuan inflow from main investors, 27.89 million yuan outflow from retail investors [3]

Core Points - The company announced an adjustment to the management committee of its 2023 employee stock ownership plan [1] - The adjustment was made due to the election of Jiang Shiping as a non-independent director of the company, which required him to resign from the management committee [1] - Wang Xiaohong was elected as a new member of the management committee to protect the overall interests of the employee stock ownership plan [1] Summary by Sections - **Employee Stock Ownership Plan**: The company held a meeting on August 1, 2025, to discuss the management committee of the 2023 employee stock ownership plan, resulting in the election of a new member [1] - **Committee Member Changes**: Jiang Shiping's election to the board necessitated his resignation from the management committee, as per the company's regulations [1] - **New Appointment**: Wang Xiaohong was appointed to the management committee, ensuring she does not hold any significant positions in the company or its controlling entities [1]

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-085 王晓红女士未在公司控股股东或者实际控制人单位担任职务，不属于持有公 司 5%以上股东、实际控制人、董事、监事、高级管理人员，且与前述主体不存 在关联关系。 特此公告。 绿康生化股份有限公司 董 事 会 2025 年 8 月 1 日 绿康生化股份有限公司 关于调整 2023 年员工持股计划管理委员会委员 的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于 2025 年 8 月 1 日以现场结合通讯表决的方式召开 2023 年员工持股计划第二次持有人会议，审 议通过了《关于调整 2023 年员工持股计划管理委员会委员的议案》。 鉴于公司本次员工持股计划管理委员会委员江世平先生当选公司第五届董 事会非独立董事，根据公司《2023 年员工持股计划》第十二章的相关规定："参 加本员工持股计划的公司董事、监事、高级管理人员已承诺不担任管理委员会任 何职务"，因此其辞去管理委员会委员职务。为了更好地保障员工持股计划的整 体利益，本次持有人 ...

Core Viewpoint - The company *ST Lvkang (002868) has received a notification regarding the relocation of its production facilities to improve environmental conditions and comply with local industrial planning [1] Group 1: Company Announcement - The company has been notified by the Fujian Pucheng Industrial Park Management Committee about the relocation of its facilities, including the South Pucheng Ecological Park and Fujian Green An Biological Pesticide Co., Ltd [1] - The relocation is driven by the need to address environmental inspection issues and improve air quality in the urban area as residential zones are increasingly close to the current facilities [1] - The company’s current production operations at the South Pucheng facility and Fujian Green An Biological are still ongoing, and no formal relocation compensation agreement has been signed yet [1] Group 2: Impact on Operations - The specific compensation amount for the relocation is yet to be determined, as it will depend on the formal agreement that has not been finalized [1] - The overall impact of the relocation on the company's operational performance cannot be assessed at this time due to the lack of a signed compensation agreement [1]

Core Viewpoint - The company *ST Green Health (002868.SZ) has received a notification regarding the relocation of its production facilities to improve environmental conditions and comply with local industrial planning [1] Group 1: Company Operations - The company operates two production facilities located in the Nanpu Ecological Park and the Putan Biological Industry Park [1] - The subsidiary Fujian Green An Biological Pesticide Co., Ltd. is also situated in the Nanpu Ecological Park [1] - As of the announcement date, both the Nanpu facility and the Fujian Green An facility are still in normal production operations [1] Group 2: Environmental and Regulatory Context - The relocation is part of a broader initiative to address environmental inspection issues and enhance air quality in the urban area [1] - The decision to relocate is driven by the increasing proximity of residential areas to the Nanpu Ecological Park due to urban expansion [1] - The relocation aligns with the new round of industrial planning adjustments in Pucheng County aimed at promoting industrial clustering [1]

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-084 绿康生化股份有限公司 关于公司南浦厂区及控股子公司厂区拟搬迁的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、拟搬迁基本概况 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于近日收到福建浦城 工业园区管理委员会出具的《关于启动南浦生态园区绿康生化股份有限公司及福建绿安 生物农药有限公司厂区搬迁和用地收储工作的通知》。绿康生化现有两个厂区分别位于 南浦生态园区（简称"南浦厂区"）、浦潭生物产业园区。控股子公司福建绿安生物农 药有限公司（简称"福建绿安生物"）厂区位于南浦生态园区。随着浦城县经济发展、 城区扩容，居民住宅区距离南浦生态园区越来越近，为进一步落实环保督察问题整改、 有效改善城区空气质量、建设美丽城市，同时为加快推进产业集聚，根据浦城县新一轮 的产业规划调整，将绿康生化南浦厂区及福建绿安生物厂区搬迁至浦潭生物产业园区。 截至公告披露日，拟搬迁的绿康生化南浦厂区及福建绿安生物厂区仍在正常生产经 营。 二、对公司的影响 鉴于目前尚未签署正式搬迁补偿协议，具体补偿金 ...

证券之星消息，7月31日动物保健板块较上一交易日下跌0.43%，大禹生物领跌。当日上证指数报收于 3573.21，下跌1.18%。深证成指报收于11009.77，下跌1.73%。动物保健板块个股涨跌见下表： 从资金流向上来看，当日动物保健板块主力资金净流出1611.97万元，游资资金净流出6281.9万元，散户 资金净流入7893.87万元。动物保健板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300871 回盛生物 | | 6787.00万 | 7.85% | -4042.91万 | -4.68% | -2744.09万 | -3.17% | | 600201 | 生物股份 | 2619.98万 | 9.14% | -534.51万 | -1.86% | -2085.47万 | -7.28% | | 002868 *ST绿康 | | 940.97万 | 10.50% | -518.20 ...